AIBOTICS, INC. (AIBT) stock: key figures, P/E, revenue and dividend

Health Care · United States

Price
0.00 USD
Market cap
2.64 m USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–

AIBOTICS, INC. financials

Fiscal year2025
Revenue2,183.00 USD
Gross profit2,183.00 USD
Operating income-1.84 m USD
EBIT-1.99 m USD
Net income-2.22 m USD

Full history since 2017, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About AIBOTICS, INC.

Aibotics Inc., together with its subsidiaries, engages in the study of psychedelics for the treatment of mental health issues in the United States. It provides psychedelic-enhanced holistic methodologies for the treatment of palliative care, depression, and anxiety. The company was formerly known as Mycotopia Therapies, Inc. and changed its name to Aibotics Inc. in February 2025. Aibotics Inc. is based in Miami, Florida.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.